| 形态 | Liquid |
|---|---|
| 克隆性 | Monoclonal |
| 抗体亚型 | Interleukin 1 Receptor Accessory Protein (human) f |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 1mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | IL1F1, Interleukin-1 alpha, IL1A, Hematopoietin-1, IL-1 alpha, Interleukin-1 beta, IL1B, Catabolin, IL1F2, IL-1 beta |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P01583 & P01584 |
| 背景信息 | Goflikicept (RPH 104) is a fusion protein that selectively binds and inactivates both circulating IL-1β and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI). • Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure., PMID:31836429 • Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis., PMID:33200890 • Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance., PMID:33037057 • The interactions between interleukin-1 family genes: IL1A, IL1B, IL1RN, and obesity parameters., PMID:35139823 • Targeting IL-1β in the Treatment of Atherosclerosis., PMID:33362770 • IL-1 family cytokines in cardiovascular disease., PMID:29198612 • Potential of cannabidiol as acne and acne scar treatment: novel insights into molecular pathways of pathophysiological factors., PMID:38904694 • IL1A and IL1B gene polymorphisms and keratoconus susceptibility: evidence from an updated meta-analysis., PMID:33978542 • Association between the IL-1A, IL-1B and IL-1R polymorphisms and lymphoma., PMID:34159887 • Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies., PMID:32825489 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 6052 |
| 磺胺氯吡嗪单抗 | 6037 |
| 呋喃苯烯酸钠单抗 | 5778 |
| 呋喃它酮代谢物(2-NPAMOZ)单抗 | 5812 |
| 呋喃西林代谢物(2-NPSEM)单抗 | 5615 |
| 磺胺喹恶啉单抗 | 5922 |
| 苯丙酸诺龙单抗 | 5833 |
| 司帕沙星单抗 | 5647 |
| 妥布霉素单抗 | 5821 |
| 甲氧氯普胺单抗 | 5644 |
| 莫能菌素单抗 | 5832 |
| 多粘菌素B(粘菌素)单抗 | 6145 |
| 磺胺类单抗 | 6088 |
| 托灭酸(托芬那酸)单抗 | 5662 |
| 卡洛芬单抗 | 5626 |
| 喹乙醇代谢物MQCA单抗 | 5759 |
| 氟尼辛单抗 | 5829 |
| 磺胺二甲嘧啶(SM2)单抗 | 5517 |
| 诺龙(19-去甲睾酮)单抗 | 5634 |
| 阿苯达唑-2-氨基砜单抗 | 5561 |